230 related articles for article (PubMed ID: 22024293)
21. Malignant pleural mesothelioma presenting as low back pain: diagnosed by bone scan coordinating with F-18 FDG PET/CT.
Huang YC; Tu DG; Wu JD; Lee MY
Spine (Phila Pa 1976); 2009 Oct; 34(21):E780-3. PubMed ID: 19934799
[TBL] [Abstract][Full Text] [Related]
22. In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.
Wild D; Eyrich GK; Ciernik IF; Stoeckli SJ; Schuknecht B; Goerres GW
J Craniomaxillofac Surg; 2006 Jan; 34(1):9-16. PubMed ID: 16343913
[TBL] [Abstract][Full Text] [Related]
23. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
24. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
25. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
26. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging of malignant lymphoma.
Vermoolen MA; Kersten MJ; Fijnheer R; van Leeuwen MS; Kwee TC; Nievelstein RA
Expert Rev Hematol; 2011 Apr; 4(2):161-71. PubMed ID: 21495926
[TBL] [Abstract][Full Text] [Related]
28. Imaging of primary central nervous system lymphoma.
Tang YZ; Booth TC; Bhogal P; Malhotra A; Wilhelm T
Clin Radiol; 2011 Aug; 66(8):768-77. PubMed ID: 21513925
[TBL] [Abstract][Full Text] [Related]
29. Evolving role of 18F-FDG-PET/CT for the body tumor and metastases in pediatrics.
Chen Z; Li X; Li F; Ouyang Q; Yu T
Eur J Radiol; 2010 Sep; 75(3):329-35. PubMed ID: 20576385
[TBL] [Abstract][Full Text] [Related]
30. Musculoskeletal applications of PET/MR.
Lee IS; Jin YH; Hong SH; Yang SO
Semin Musculoskelet Radiol; 2014 Apr; 18(2):203-16. PubMed ID: 24715451
[TBL] [Abstract][Full Text] [Related]
31. Update on pediatric leukemia and lymphoma imaging.
Averill LW; Acikgoz G; Miller RE; Kandula VV; Epelman M
Semin Ultrasound CT MR; 2013 Dec; 34(6):578-99. PubMed ID: 24332209
[TBL] [Abstract][Full Text] [Related]
32. Whole-body imaging of bone marrow.
Schmidt GP; Reiser MF; Baur-Melnyk A
Semin Musculoskelet Radiol; 2009 Jun; 13(2):120-33. PubMed ID: 19455475
[TBL] [Abstract][Full Text] [Related]
33. [Clinical diagnostic imaging (including FDG-PET/CT)].
Torizuka T
Nihon Rinsho; 2012 Apr; 70 Suppl 2():198-201. PubMed ID: 23133952
[No Abstract] [Full Text] [Related]
34. Detection of multiple myeloma by PET/CT in a patient with colon cancer.
Chang CY; Peng YJ; Shen DH; Huang WS; Cherng SC
Clin Nucl Med; 2008 May; 33(5):367-70. PubMed ID: 18431161
[TBL] [Abstract][Full Text] [Related]
35. The role of PET/CT in the evaluation of skeletal metastases.
Kannivelu A; Loke KS; Kok TY; Osmany SY; Ali SZ; Suat-Jin L; Ng DC
Semin Musculoskelet Radiol; 2014 Apr; 18(2):149-65. PubMed ID: 24715447
[TBL] [Abstract][Full Text] [Related]
36. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.
Dimopoulos M; Terpos E; Comenzo RL; Tosi P; Beksac M; Sezer O; Siegel D; Lokhorst H; Kumar S; Rajkumar SV; Niesvizky R; Moulopoulos LA; Durie BG;
Leukemia; 2009 Sep; 23(9):1545-56. PubMed ID: 19421229
[TBL] [Abstract][Full Text] [Related]
37. Whole-body magnetic resonance imaging and prostate cancer metastases: a new gold standard of detection, but does it help us and at what cost?
Linton KD; Catto JW
Eur Urol; 2012 Jul; 62(1):76-7. PubMed ID: 22424664
[No Abstract] [Full Text] [Related]
38. [Prostate cancer - detection of metastases: MRI or scintigraphy better?].
Schilling D
Aktuelle Urol; 2013 May; 44(3):173-4. PubMed ID: 23712268
[No Abstract] [Full Text] [Related]
39. Posttherapy imaging of musculoskeletal neoplasms.
Garner HW; Kransdorf MJ; Peterson JJ
Radiol Clin North Am; 2011 Nov; 49(6):1307-23, vii. PubMed ID: 22024300
[TBL] [Abstract][Full Text] [Related]
40. Fluorine-18-fluorodeoxyglucose positron emission tomography in technetium-99m-hydroxymethylenediphosphate negative bone tumors.
Sasaki M; Ichiya Y; Kuwabara Y; Otsuka M; Fukumura T; Kawai Y; Koga H; Masuda K
J Nucl Med; 1993 Feb; 34(2):288-90. PubMed ID: 8429349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
